Pharmacokinetic analysis of mycophenolic acid (MPA), free MPA and MPA-glucuronide (MPAG) in pediatric renal transplant recipients - A multicenter study.

被引：0

作者：

Tonshoff, B

Weber, L

Armstrong, VW

Lamersdorf, T

Andreeva, M

Niedmann, PD

Schutz, E

Wiesel, M

Mandelbaum, A

Zimmerhackl, LB

Mehls, O

Oellerich, M

机构：

[1] UNIV HEIDELBERG, CHILDRENS HOSP, D-6900 HEIDELBERG, GERMANY

[2] UNIV GOTTINGEN, DEPT CLIN CHEM, D-3400 GOTTINGEN, GERMANY

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 1997年 / 8卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A3282 / A3282

页数：1

共 50 条

[41] Validated LC-MS/MS method for quantitation of total and free mycophenolic acid concentration and its application to a pharmacokinetic study in pediatric renal transplant recipients
Liu, Yan
Liu, Longshan
Li, Jingjie
Fu, Qian
Zhang, Huanxi
Wu, Chenglin
Li, Jun
Zhong, Guoping
Zheng, Yifan
Chen, Xiao
Wang, Changxi
Chen, Pan
[J]. BIOMEDICAL CHROMATOGRAPHY, 2021, 35 (02)
[42] Population pharmacokinetic analysis of mycophenolic acid in renal transplant recipients following oral administration of mycophenolate mofetil
Shum, B
Duffull, SB
Taylor, PJ
Tett, SE
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 56 (02) : 188 - 197
[43] Influence of MRP2 on MPA pharmacokinetics in renal transplant recipients-results of the Pharmacogenomic Substudy within the Symphony Study
Lloberas, Nuria
Torras, Juan
Ma Cruzado, Josep
Andreu, Franc
Oppenheimer, Federico
Sanchez-Plumed, Jaime
Angel Gentil, Miguel
Brunet, Merce
Ekberg, Henrik
Ma Grinyo, Josep
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (11) : 3784 - 3793
[44] Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling
Yan Rong
Jenny Wichart
Lorraine Hamiwka
Tony K. L. Kiang
[J]. Clinical Pharmacokinetics, 2023, 62 : 1289 - 1303
[45] Significant Effects of Renal Function on Mycophenolic Acid Total Clearance in Pediatric Kidney Transplant Recipients with Population Pharmacokinetic Modeling
Rong, Yan
Wichart, Jenny
Hamiwka, Lorraine
Kiang, Tony K. L.
[J]. CLINICAL PHARMACOKINETICS, 2023, 62 (09) : 1289 - 1303
[46] UTILITY OF MYCOPHENOLIC ACID AREA UNDER THE CURVE (MPA-AUC) AFTER MYCOPHENOLATE MOFETIL DOSE REDUCTION (MMF-DR) IN KIDNEY TRANSPLANT RECIPIENTS
Malaweera, A.
Ellis, A.
Frauman, A.
Lee, D.
[J]. NEPHROLOGY, 2020, 25 : 14 - 14
[47] Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: A population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients
van Hest, Reinier M.
Mathot, Ron A. A.
Pescovitz, Mark D.
Gordon, Robert
Mamelok, Richard D.
van Gelder, Teun
[J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (03): : 871 - 880
[48] Elective conversion from cellcept to Myfortic under control of mycophenolic acid (MPA) concentration in stable heart transplant recipients-1 year follow-up
Zakliczynski, M. W.
Zembala, M.
[J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S167 - S167
[49] Adequate Early Mycophenolic Acid (MPA) Exposure Achieved by Initially Intensified Dosing Regimen of Enteric-Coated Mycophenolate Sodium (EC-MPS) in De Novo Renal Transplant Recipients.
Arns, W.
Sommerer, C.
Tedesco-Silva, H.
Contieri, F.
Kuypers, D.
Vaidya, S.
Budde, K.
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 395 - 396
[50] THE MAXIMUM TOLERATED DOSE OF MYCOPHENOLIC ACID (MPA) IS HIGHER WITH ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) COMPARED TO MYCOPHENOLATE MOFETIL (MMF) IN KIDNEY TRANSPLANT RECIPIENTS: RESULTS OF A RANDOMIZED, MULTICENTER TRIAL
Shehata, Magdi
Bhandari, Sunil
Venkat-Raman, Gopalakrishnan
Moore, Richard
D'Souza, Richard
[J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 109 - 110

← 1 2 3 4 5 →